Suppr超能文献

29个国家的流感疫苗接种情况。截至1997年的最新信息。

Influenza vaccination in 29 countries. An update to 1997.

作者信息

Ambrosch F, Fedson D S

机构信息

Institute for Specific Prophylaxis and Tropical Medicine, University of Vienna, Austria.

出版信息

Pharmacoeconomics. 1999;16 Suppl 1:47-54. doi: 10.2165/00019053-199916001-00007.

Abstract

OBJECTIVE

This report updates for 1996 and 1997 our 2 earlier reports on the use of influenza vaccination in various countries.

METHODS

Methods for obtaining information on influenza vaccine use from 1980 to 1995 in each country are described in our earlier reports. The current report includes data for 29 countries.

RESULTS

Among 16 countries of Western Europe, vaccine use increased substantially in The Netherlands, Finland (1996) and in Ireland (1997). In the remaining 13 countries, vaccine use increased somewhat or remained the same. In the US, vaccine use increased steadily throughout the 1990s, reaching a level of 281 doses per 1000 population in 1997. In New Zealand, there was a substantial increase in 1997, while vaccine use remained relatively unchanged in Canada, Australia and Korea. In Japan and Singapore, little or no influenza vaccine was used. In 1997, 6 countries in Central Europe used modest amounts of influenza vaccine. Among all 29 countries, in 1997 all but 3 (the UK, Ireland and Denmark) had age-based recommendations for influenza vaccination. This changed in 1998 when the UK and Denmark recommended vaccination for persons > or = 75 years and > or = 65 years of age, respectively. Ireland is considering an age-based recommendation. Many countries provide reimbursement for influenza vaccination through national or social health insurance, at least for some recommended groups. In virtually all countries, however, many persons pay for vaccination themselves. The levels of vaccine use in different countries are not related to per capita healthcare spending. Instead, they reflect different levels of awareness of influenza as an important disease and the effectiveness of vaccination in its prevention.

CONCLUSIONS

Influenza vaccination has continued to increase or has stabilised in most developed countries, and vaccine is also being used in several developing countries. In spite of much progress, however, the full benefits of influenza vaccination have yet to be achieved in any country.

摘要

目的

本报告更新了1996年和1997年我们之前关于各国流感疫苗使用情况的两份报告。

方法

我们之前的报告中描述了获取各国1980年至1995年流感疫苗使用信息的方法。本报告涵盖了29个国家的数据。

结果

在西欧的16个国家中,荷兰、芬兰(1996年)和爱尔兰(1997年)的疫苗使用量大幅增加。在其余13个国家,疫苗使用量有所增加或保持不变。在美国,整个20世纪90年代疫苗使用量稳步上升,1997年达到每1000人口281剂的水平。在新西兰,1997年有大幅增长,而加拿大、澳大利亚和韩国的疫苗使用量相对保持不变。在日本和新加坡,流感疫苗使用量很少或几乎没有使用。1997年,中欧的6个国家使用了适量的流感疫苗。在所有29个国家中,1997年除了3个国家(英国、爱尔兰和丹麦)外,其他国家都有基于年龄的流感疫苗接种建议。1998年情况发生了变化,英国和丹麦分别建议75岁及以上和65岁及以上的人群接种疫苗。爱尔兰正在考虑基于年龄的建议。许多国家通过国家或社会医疗保险为流感疫苗接种提供报销,至少为一些推荐人群提供报销。然而,在几乎所有国家,许多人都是自费接种疫苗。不同国家的疫苗使用水平与人均医疗保健支出无关。相反,它们反映了对流感作为一种重要疾病的不同认识水平以及疫苗在预防方面的有效性。

结论

在大多数发达国家,流感疫苗接种持续增加或趋于稳定,一些发展中国家也在使用疫苗。然而,尽管取得了很大进展,但流感疫苗接种的全部益处尚未在任何一个国家实现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验